New ETF allows you to invest in up-and-coming Chinese biotech companies

The sector is at a unique, even revolutionary moment in time: already developing world-class, cutting-edge therapeutics in areas like oncology and gene therapy, and getting a boost from a variety of new policies and regulatory factors, its creator says.